Connection

Gregory Sahlem to Humans

Back to Details
This is a "connection" page, showing publications Gregory Sahlem has written about Humans.
Gregory Sahlem
Connection Strength
0.251
Humans
  1. A two-site, open-label, non-randomized trial comparing Focal Electrically-Administered Seizure Therapy (FEAST) and right unilateral ultrabrief pulse electroconvulsive therapy (RUL-UBP ECT). Brain Stimul. 2020 Sep - Oct; 13(5):1416-1425.
    View in: PubMed
    Score: 0.028
  2. Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. Int Rev Psychiatry. 2018 06; 30(3):216-225.
    View in: PubMed
    Score: 0.025
  3. Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55.
    View in: PubMed
    Score: 0.023
  4. Expanded Safety and Efficacy Data for a New Method of Performing Electroconvulsive Therapy: Focal Electrically Administered Seizure Therapy. J ECT. 2016 Sep; 32(3):197-203.
    View in: PubMed
    Score: 0.022
  5. Oscillating Square Wave Transcranial Direct Current Stimulation (tDCS) Delivered During Slow Wave Sleep Does Not Improve Declarative Memory More Than Sham: A Randomized Sham Controlled Crossover Study. Brain Stimul. 2015 May-Jun; 8(3):528-34.
    View in: PubMed
    Score: 0.020
  6. Adjunctive triple chronotherapy (combined total sleep deprivation, sleep phase advance, and bright light therapy) rapidly improves mood and suicidality in suicidal depressed inpatients: an open label pilot study. J Psychiatr Res. 2014 Dec; 59:101-7.
    View in: PubMed
    Score: 0.019
  7. The Effects of Focal Electrically Administered Seizure Therapy Compared With Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy on Suicidal Ideation: A 2-Site Clinical Trial. J ECT. 2021 12 01; 37(4):256-262.
    View in: PubMed
    Score: 0.008
  8. Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial. Drug Alcohol Depend. 2021 12 01; 229(Pt B):109111.
    View in: PubMed
    Score: 0.008
  9. TMS and CBT-I for comorbid depression and insomnia. Exploring feasibility and tolerability of transcranial magnetic stimulation (TMS) and cognitive behavioral therapy for insomnia (CBT-I) for comorbid major depressive disorder and insomnia during the COVID-19 pandemic. Brain Stimul. 2021 Nov-Dec; 14(6):1508-1510.
    View in: PubMed
    Score: 0.008
  10. Sleep and substance use disorder treatment: A preliminary study of subjective and objective assessment of sleep during an intensive outpatient program. Am J Addict. 2021 09; 30(5):477-484.
    View in: PubMed
    Score: 0.008
  11. NMDA-receptor agonist reveals LTP-like properties of 10-Hz rTMS in the human motor cortex. Brain Stimul. 2021 May-Jun; 14(3):619-621.
    View in: PubMed
    Score: 0.007
  12. Treatment of Adults with Autism and Major Depressive Disorder Using Transcranial Magnetic Stimulation: An Open Label Pilot Study. Autism Res. 2020 03; 13(3):346-351.
    View in: PubMed
    Score: 0.007
  13. Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead. Neurosci Biobehav Rev. 2019 09; 104:118-140.
    View in: PubMed
    Score: 0.007
  14. Insomnia severity during early abstinence is related to substance use treatment completion in adults enrolled in an intensive outpatient program. J Subst Abuse Treat. 2019 09; 104:97-103.
    View in: PubMed
    Score: 0.007
  15. Neurogenic Pulmonary Edema Complicating ECT. J ECT. 2018 06; 34(2):78.
    View in: PubMed
    Score: 0.006
  16. Biological correlates of self-reported new and continued abstinence in cannabis cessation treatment clinical trials. Drug Alcohol Depend. 2018 06 01; 187:270-277.
    View in: PubMed
    Score: 0.006
  17. The role of rTMS for patients with severe PTSD and depression. Evid Based Ment Health. 2018 Feb; 21(1):39-40.
    View in: PubMed
    Score: 0.006
  18. Transcranial magnetic stimulation of the dorsal lateral prefrontal cortex inhibits medial orbitofrontal activity in smokers. Am J Addict. 2017 Dec; 26(8):788-794.
    View in: PubMed
    Score: 0.006
  19. The Role of Amantadine Withdrawal in 3 Cases of Treatment-Refractory Altered Mental Status. J Psychiatr Pract. 2017 05; 23(3):191-199.
    View in: PubMed
    Score: 0.006
  20. Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex reduces resting-state insula activity and modulates functional connectivity of the orbitofrontal cortex in cigarette smokers. Drug Alcohol Depend. 2017 05 01; 174:98-105.
    View in: PubMed
    Score: 0.006
  21. Neuroversion: using electroconvulsive therapy as a bridge to deep brain stimulation implantation. Neurocase. 2017 Feb; 23(1):26-30.
    View in: PubMed
    Score: 0.006
  22. Five-Year Follow-Up of Bilateral Epidural Prefrontal Cortical Stimulation for Treatment-Resistant Depression. Brain Stimul. 2016 Nov - Dec; 9(6):897-904.
    View in: PubMed
    Score: 0.005
  23. Reward circuit DBS improves Parkinson's gait along with severe depression and OCD. Neurocase. 2016; 22(2):201-4.
    View in: PubMed
    Score: 0.005
  24. Safe management of a bipolar depressed patient with prefrontal repetitive transcranial magnetic stimulation (rTMS) Over 7 years and >2 million stimuli. Brain Stimul. 2014 Nov-Dec; 7(6):919-21.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.